Room temperature neutron crystallography of drug resistant HIV-1 protease uncovers limitations of X-ray structural analysis at 100K
Journal Article
·
· Journal of Medicinal Chemistry
- Univ. of Tennessee, Knoxville, TN (United States). Joint Inst. of Biological Sciences
- Science and Technology Facilities Council (STFC), Oxford (United Kingdom). Rutherford Appleton Lab., ISIS Neutron Source
- Inst. Laue-Langevin (ILL), Grenoble (France)
- National Inst. of Health (NIH), Bethesda, MD (United States)
- Georgia State Univ., Atlanta, GA (United States)
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
HIV-1 protease inhibitors are crucial for treatment of HIV-1/AIDS, but their effectiveness is thwarted by rapid emergence of drug resistance. To better understand binding of clinical inhibitors to resistant HIV-1 protease, we used room-temperature joint X-ray/neutron (XN) crystallography to obtain an atomic-resolution structure of the protease triple mutant (V32I/I47V/V82I) in complex with amprenavir. The XN structure reveals a D+ ion located midway between the inner Oδ1 oxygen atoms of the catalytic aspartic acid residues. Comparison of the current XN structure with our previous XN structure of the wild-type HIV-1 protease-amprenavir complex suggests that the three mutations do not significantly alter the drug–enzyme interactions. This is in contrast to the observations in previous 100 K X-ray structures of these complexes that indicated loss of interactions by the drug with the triple mutant protease. These findings, thus, uncover limitations of structural analysis of drug binding using X-ray structures obtained at 100 K.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1361359
- Journal Information:
- Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 5 Vol. 60; ISSN 0022-2623
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I
Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors
Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters
Journal Article
·
Sat May 11 20:00:00 EDT 2019
· Biochemical and Biophysical Research Communications
·
OSTI ID:1531006
Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors
Journal Article
·
Thu Mar 15 00:00:00 EDT 2012
· Protein Sci.
·
OSTI ID:1034955
Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters
Journal Article
·
Fri Oct 22 00:00:00 EDT 2010
· FEBS J.
·
OSTI ID:1002740